Dipexium Pharmaceuticals, Inc.: Clinical Trials

2 completed. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Completed 2

Follow Dipexium Pharmaceuticals, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care - Diabetic Foot Infection	Phase 3	Completed	Dipexium Pharmaceuticals, Inc.	189	2014-06-01	2017-06-14
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care - Diabetic Foot Infection	Phase 3	Completed	Dipexium Pharmaceuticals, Inc.	200	2014-06-01	2017-06-14

Interventions

pexiganan (2)

Countries

United States (2)

Top investigators

Michael H. Silverman, MD (2)

Results publications

PMID 36781451